Evaluating HER2 amplification and overexpression in breast cancer. (Q52936177)

9 May 2018

title

Evaluating HER2 amplification and overexpression in breast cancer. (English)

1 reference

9 May 2018

1 reference

2

1 reference

9 May 2018

author name string

Bartlett JM

1

1 reference

9 May 2018

Mallon EA

3

1 reference

9 May 2018

Watters AD

4

1 reference

9 May 2018

Reeves JR

5

1 reference

9 May 2018

Stanton P

6

1 reference

9 May 2018

Richmond J

7

1 reference

9 May 2018

Donald B

8

1 reference

9 May 2018

Ferrier R

9

1 reference

9 May 2018

Cooke TG

10

1 reference

9 May 2018

publication date

1 November 2001

1 reference

9 May 2018

published in

Journal of Pathology

1 reference

9 May 2018

volume

195

1 reference

9 May 2018

issue

4

1 reference

9 May 2018

page(s)

422-428

1 reference

9 May 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

cites work

1 reference

Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

21 January 2018

1 reference

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

21 January 2018

1 reference

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

21 January 2018

1 reference

Oncogene amplification and expression. Importance of methodologic considerations

21 January 2018

1 reference

Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer

21 January 2018

1 reference

Immunohistochemical detection of HER2/neu in patients with axillary lymph node negative breast carcinoma. A study of epidemiologic risk factors, histologic features, and prognosis.

21 January 2018

1 reference

Human squamous cell lung cancers express increased epidermal growth factor receptors

21 January 2018

1 reference

c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival

21 January 2018

1 reference

A scoring system for immunohistochemical staining: consensus report of the task force for basic research of the EORTC-GCCG. European Organization for Research and Treatment of Cancer-Gynaecological Cancer Cooperative Group

21 January 2018

1 reference

Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?

21 January 2018

1 reference

Aneusomy of chromosomes 7 and 17 predicts the recurrence of transitional cell carcinoma of the urinary bladder

21 January 2018

1 reference

Recommendations for HER2 testing in the UK.

21 January 2018

1 reference

Her-2/neu analysis in archival tissue samples of human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization

21 January 2018

1 reference

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

21 January 2018

1 reference

Expression and amplification of the HER-2/ neu (c-erbB-2) protooncogene in epithelial ovarian tumors and cell lines

21 January 2018

1 reference

Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site

21 January 2018

1 reference

ERBB2 oncogene in human breast cancer and its clinical significance

21 January 2018

1 reference

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

21 January 2018

1 reference

c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases

21 January 2018

1 reference

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

21 January 2018

1 reference

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

21 January 2018

1 reference

Localization of EGF receptors in frozen tissue sections by antibody and biotinylated EGF-based techniques

21 January 2018

1 reference

Quantitative radioimmunohistochemical measurements of p185(erbB-2) in frozen tissue sections

21 January 2018

1 reference

Estrogen receptors in 699 primary breast cancers: A comparison of immunohistochemical and biochemical methods

21 January 2018

1 reference

Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry

21 January 2018

1 reference

Chromosomal aberrations in transitional cell carcinoma that are predictive of disease outcome are independent of polyploidy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.971

1 reference

9 May 2018

1 reference

9 May 2018